» Articles » PMID: 6816585

Opsonization and Phagocytosis of Mucoid and Non-mucoid Pseudomonas Aeruginosa Strains

Overview
Specialty Microbiology
Date 1982 Apr 1
PMID 6816585
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction between Pseudomonas aeruginosa strains (6 non-mucoid and 4 mucoid strains), serum factors and phagocytic cells was investigated. Strains were incubated in different concentrations of normal serum, chelated serum (with only the alternative complement pathway intact), IgG, Cls, C2 and C3 deficient serum and immune serum. After incubation complement consumption, C3 fixation and phagocytosis by polymorphonuclear leukocytes (PMN) were measured. In contrast to normal serum, immune serum raised against a mucoid and a non-mucoid strain exhibited heat-stable opsonic activity. All ten Pseudomonas aeruginosa strains were able to activate complement in 20% normal serum, leading to deposition of the activated form of the third complement component on the bacterial cell wall and to subsequent recognition and phagocytosis. One mucoid and four non-mucoid strains activated the alternative complement pathway and were effectively opsonized in chelated or in Cls, C2 or IgG deficient serum. Although mucoid strains were less able to activate complement via the alternative route, no differences were observed in opsonic requirements and phagocytosis between mucoid and non-mucoid strains.

Citing Articles

Age-related variations in the bactericidal activity of human sera against .

Khan A, Tauseef I, Aalia B, Khan M, Akbar S, Sultana N Cent Eur J Immunol. 2018; 43(1):18-25.

PMID: 29731689 PMC: 5927169. DOI: 10.5114/ceji.2018.74869.


Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Folkesson A, Jelsbak L, Yang L, Krogh Johansen H, Ciofu O, Hoiby N Nat Rev Microbiol. 2012; 10(12):841-51.

PMID: 23147702 DOI: 10.1038/nrmicro2907.


Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.

Engels W, Endert J, Kamps M, van Boven C Infect Immun. 1985; 49(1):182-9.

PMID: 3924827 PMC: 262076. DOI: 10.1128/iai.49.1.182-189.1985.


Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro.

Krieg D, Helmke R, German V, MANGOS J Infect Immun. 1988; 56(12):3173-9.

PMID: 3141284 PMC: 259720. DOI: 10.1128/iai.56.12.3173-3179.1988.


Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

May T, Shinabarger D, Maharaj R, Kato J, Chu L, DeVault J Clin Microbiol Rev. 1991; 4(2):191-206.

PMID: 1906371 PMC: 358191. DOI: 10.1128/CMR.4.2.191.

References
1.
Sensakovic J, Bartell P . The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection. J Infect Dis. 1974; 129(2):101-9. DOI: 10.1093/infdis/129.2.101. View

2.
Verbrugh H, van Dijk W, Peters R, van der Tol M, Peterson P, Verhoef J . Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2. Immunology. 1979; 36(3):391-7. PMC: 1457553. View

3.
Verhoef J, Peterson P, Quie P . Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria. J Immunol Methods. 1977; 14(3-4):303-11. DOI: 10.1016/0022-1759(77)90141-7. View

4.
Whitecar Jr J, Luna M, Bodey G . Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci. 1970; 60(4):216-23. DOI: 10.1097/00000441-197010000-00003. View

5.
Tapper M, Armstrong D . Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report. J Infect Dis. 1974; 130 Suppl(0):S14-23. DOI: 10.1093/infdis/130.supplement.s14. View